title: Does Stroke Severity for Repeated Thrombolysis Matter? Response to the Letter by Wu et al.
authors.affiliation: Department of Neurology, University of Heidelberg, Heidelberg, Germany.
authors.forename: Mona
authors.initials: M
authors.lastname: Laible
authors.forename: Ekkehart
authors.initials: E
authors.lastname: Jenetzky
authors.forename: Peter Arthur
authors.initials: PA
authors.lastname: Ringleb
authors.forename: Timolaos
authors.initials: T
authors.lastname: Rizos
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D020521:Stroke / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator